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Abstract
The Italian Consensus Position Statement on Diagnosis, Treatment and Prevention of Obesity in Children and
Adolescents integrates and updates the previous guidelines to deliver an evidence based approach to the disease.
The following areas were reviewed: (1) obesity definition and causes of secondary obesity; (2) physical and
psychosocial comorbidities; (3) treatment and care settings; (4) prevention.
The main novelties deriving from the Italian experience lie in the definition, screening of the cardiometabolic and
hepatic risk factors and the endorsement of a staged approach to treatment. The evidence based efficacy of
behavioral intervention versus pharmacological or surgical treatments is reported. Lastly, the prevention by
promoting healthful diet, physical activity, sleep pattern, and environment is strongly recommended since the
intrauterine phase.
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Background
Contrasting pediatric obesity is among the priority goals
in the healthcare agenda of the Italian National Healthcare
System. Beyond the high prevalence and persistence of
pediatric obesity [1], robust evidence demonstrates that
physical and psychosocial complications are already
present in obese children [2] and worsen in adulthood.
Therefore, prevention and treatment of pediatric obesity
and complications are key strategic goals, in order to re-
duce morbidity, mortality, and expected costs for the care
of obese adults.
The very fruitful scientific research on pediatric obesity of
the last decade justified to update the guidelines, in order
to provide the best evidence-based reccomendations.
Therefore, the Italian Society for Pediatric Endocrinology
and Diabetology and the Italian Society of Pediatrics, with
other Pediatric Societies joined in the common objective of
contrasting pediatric obesity, made this Consensus on
“Diagnosis, therapy and prevention of obesity in children
and adolescents”, updating the document published in
2006 [3].
Methods
Four main topics were defined: 1) diagnostic criteria,
secondary obesity; 2) comorbidities; 3) treatment and
care settings; 4) prevention. Coordinators were identified
for each topic and specific questions listed. Twenty ex-
perts’ groups were set up, embracing all the skills needed
for document processing. Each group systematically re-
vised the literature on the assigned themes limited to
the time frame 1 January 2006 to 31 May 2016 and pa-
tients’ age range 0–18 years. The article search was done
through PubMed using MeSH terms or descriptors. Sci-
entific articles, systematic reviews, meta-analysis, con-
sensus, recommendations, international and national
guidelines published on pediatric obesity even prior to
2005 were considered and deemed useful to the Consen-
sus. The level of evidence (LOE) and the grade of racco-
mendation were established in accordance with the
National Manual of Guidelines [4] (Additional file 1).
Each working group prepared a preliminary draft report-
ing LOE for each specific recommendation, followed by
a brief description of the scientific evidence in support,
epidemiological data, and any notes deemed as useful. A
Consensus Conference was held in Verona, on June 9th,
2016 in the presence of the document extensors and del-
egates of the Scientific Societies to discuss and approve
the preliminary draft. The final document was sent on
October 10th, 2016 to all the extensors and members of
the Pediatric Obesity Study Group of the Italian Society
for Pediatric Endocrinology and Diabetology and ap-
proved on 28th February 2017 in its definitive form. Lit-
erature search was updated before preparing the final
draft; no additional relevant publication was identified
which might have required a change in the statements.
Diagnosis
Diagnostic criteria for defining overweight, obesity and
severe obesity
The definition of overweight and obesity is based on the
use of percentiles of the weight-to-length ratio or body
mass index, depending on sex and age. LOE V-A
In children up to 24 months, the diagnosis of overweight
and obesity is based on the weight-to-length ratio, using
the World Health Organization (WHO) 2006 reference
curves [5]. After the age of 2 years it is based on the
Body Mass Index (BMI), using the WHO 2006 reference
system [5] up to 5 years and the WHO 2007 reference
system [6] thereafter (Table 1). The recommendation of
using the WHO standard is based on the need to
propose a reference system which, although is not an
ideal model to assess adiposity in single children or
groups, it has a greater sensitivity in identifying children
and adolescents with overweight and obesity, in a period
of particular seriousness of the pediatric obesity epidemic
in Italy. On the contrary, the Italian BMI thresholds [7]
underestimate the prevalence of obesity compared to
WHO, probably because they were based on measure-
ments taken during the epidemic increase of obesity [8].
The cut-off to define severe obesity is represented by the
BMI > 99th percentile. LOE VI-B
It has been demonstrated that the 99th percentile of
BMI identifies subjects with higher prevalence of cardio-
metabolic risk factors and persistence of severe obesity
in adulthood with respect to the lower percentiles [9].
The WHO system provides the values of the 99th per-
centile of BMI which approximate + 3 SDS from 2 years
upwards. However, as for overweight and obesity classifi-
cation, the WHO terminology for severe obesity differs
between younger (0–5 years) and older children/adoles-
cents (5–18 years): the 99th percentile identifies “obes-
ity” in the former group, and “severe obesity”in the
latter. This cautious approach is motivated by the fact
that the growth process differs between younger and
older children; moreover few data are available on the
functional significance of the cut-offs for the upper end
of the BMI-for-age distribution in pre-school age [10,
11]. A scientific statement from the American Hearth
Association proposed the 120% above the age and sex
95th percentile of BMI or an absolute BMI ≥ 35 kg/m2
(equivalent to class 2 obesity in adults) as an alternative
to the 99th percentile [12]. The impact of this system
using the WHO thresholds has yet to be assessed in
clinical practice.
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Secondary obesity
The clinical suspicion of secondary obesity arises after
careful anamnestic, anthropometric and clinical
evaluations. LOE III-A
Obesity may be ascribed to a specific cause (endocrine,
hypothalamic, genetic, iatrogenic). Therefore, clinical
history, peculiar signs and symptoms must be accurately
assessed such as: 1) onset of obesity before 5 years and/
or rapid progression, especially in association with clues
suggesting secondary causes (i.e. genetic forms); 2) con-
tinuous and/or rapid weight gain associated with re-
duced height velocity or short stature; 3) delayed
cognitive development; 4) dismorphic features; and 5)
use of drugs inducing hyperphagia (i.e. corticosteroids,
sodium valproate, risperidone, phenothiazines, ciproep-
tadine) [13].
Early-onset obesity occurring in a child with delayed
psychomotor development, cognitive deficiency, short
stature, cryptorchidism or hypogonadism, dysmorphisms
and characteristic facial features, ocular and/or auditory
alterations, is suggestive of a syndromic form [14].
Prader-Willi syndrome is the most common one, whereas
Bardet-Biedl, Alström, Cohen, Borjeson-Forssman and
Carpenter are more rarely observed [15–20]. Obesity oc-
curs frequently in children with trisomy 21, Klinefelter
and Turner syndromes [21–23].
The monogenic forms, albeit uncommon, are never-
theless the most frequent causes of obesity with early
onset compared to endocrine and syndromic forms [24]
and are due to dysregulated hunger satiety circuits [25].
Certain monogenic forms are characterized by tall or
normal stature [14]. Suspicion of syndromic or mono-
genic forms is confirmed by genetic investigations.
Comorbidities
Hypertension
Blood pressure measurement is recommended in all
children with overweight or obesity from the age of 3 years.
LOE I-A
Obesity is the main risk factor for hypertension in chil-
dren and adolescents [26, 27]. The risk increases with
obesity severity [28]. As blood pressure (BP) levels
change according to sex, age, ethnicity and obesity, the
prevalence of high BP levels and especially hypertension
is heterogeneous (7–30%) in obese children [29, 30].
White coat hypertension may cause overestimation of
the high BP prevalence, but the effect tends to disappear
if BP is measured on at least 2–3 occasions [29].
Screening can be anticipated in children < 3 years if
there is a history of neonatal complications, cardiac mal-
formations, genetic diseases, acquired or congenital kid-
ney diseases, neoplasms, drug use, illnesses which
induce increased intra-cranial pressure [31] (LOE III-B).
The definition of high BP levels requires a precise
methodology and the use of tables expressing by sex and
age the percentile of systolic and diastolic blood pressure
as a function of the height percentile. LOE III-A
The method of measuring BP and the definition of high
systolic (SBP) and diastolic BP (DBP) values are based
on the guidelines of the National High Blood Pressure
Education Program Working Group on High Blood
Pressure in Children and Adolescents and the European
Society for Hypertension (Table 2) [32, 33].
Primary forms of hypertension are mainly associated
with obesity and more frequent in children > 6 years.
Secondary forms are predominant in younger children.
Nephropathy, nephrovascular pathologies and coarcta-
tion of the aorta account for 70–90% of the causes of
secondary hypertension in pediatric age, while hypertension
by endocrine causes is rare [34]. Various drugs (steroids,
erythropoietin, theophylline, beta-stimulants, cyclosporin,
tacrolimus, tricyclic antidepressants, antipsychotics, mono-
amino oxidase inhibitors, nasal decongestants, oral contra-
ceptives, and androgens) can increase BP. If stage I
hypertension is confirmed on 3 different visits, the follow-
ing diagnostic work-up is recommended: 1) assessment of
Table 1 Diagnostic criteria to classify overweight and obesity
Age 0–2 years 2–5 years 5–18 years
Index Weight-to-lenght ratio BMI BMI
Reference WHO 2006 WHO 2006 WHO 2007
>85th percentilea At risk of overweight At risk of overweight Overweight
>97th percentilea Overweight Overweight Obesity
>99th percentilea Obesity Obesity Severe obesity
athe 85th, 97th and 99th percentiles approximate z-scores of + 1, + 2 and + 3, respectively
Table 2 Definition of the blood pressure values
Normal BP SBP and DBP < 90th percentile by gender,
age and height
High normal BP SBP and/or DBP ≥90th but <95th percentile by
gender, age and height (BP > 120/80 mmHg even
<90th percentile are considered as high normal BP).
Hypertension
(Stage I)
SBP and/or DBP ≥95th <99th percentile + 5 mmHg
by gender, age and height.
Hypertension
(Stage II)
SBP and/or DBP ≥99th percentile + 5 mmHg
by gender, age and height.
BP Blood pressure, SBP Systolic blood pressure, DBP Diastolic blood pressure
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blood urea nitrogen, creatinine, glycemia, electrolytes,
lipids, urine examination, microalbuminuria (may be influ-
enced by physical activity) (LOE II-A); 2) measurement of
glomerular filtration by formulas for renal function moni-
torig (LOE III-B); 3) echocardiography to assess organ
damage (left ventricular hypertrophy, altered cardiac struc-
ture) (LOE III-A) [35]. Left ventricular remodeling or con-
centric hypertrophy are associated with high BP levels and
other comorbidities such as visceral obesity and atherogenic
dyslipidemia [36, 37]. Weight loss and reduced sodium in-
take are recommended. If stage II hypertension or secondary
causes are present, the patient must be referred to a special-
ist for further investigations and treatment [31, 34, 35].
Prediabetes and type 2 diabetes mellitus
Fasting blood glucose measurement is recommended in all
children and adolescents with overweight and obesity since
the age of 6, as the first step for screening prediabetes and
type 2 diabetes. LOE V-A
The diagnosis of prediabetes, i.e. high fasting blood glu-
cose and impaired glucose tolerance (IGT) or overt type
2 diabetes (T2D) is based on fasting plasma glucose or
oral glucose tolerance test (OGTT) [38]. The use of
hemoglobin glycosilated A1c (HbA1c) is still controver-
sial in pediatric age [38–42]. The criteria for defining
prediabetes and T2D are summarized in Table 3. The
screening must be repeated after 3 years, unless rapid
weight increase or the development of other cardiometa-
bolic comorbidities occur. Since evidences provided
from national studies suggest that prediabetes is already
present in about 5% obese children < 10 years [43], it is
recommended to start the screening by testing fasting
glucose in all overweight or obese children after the age
of 6 years. The OGTT is indicated after the age of
10 years or at onset of puberty in agreement with the
criteria of the American Diabetes Association [38]
(Table 4). Certain conditions, such as non-alcoholic fatty
liver disease (NAFLD), fasting blood glucose ≥86 mg/dl,
or a combination of triglycerides (TG) > 100 mg/dl plus
fasting blood glucose > 80 mg/dl, or TG to
HDL-cholesterol ratio (TG/HDL-C) ≥2.2, have been as-
sociated with increased risk of IGT [44–47] and there-
fore, an OGTT may be considered in latter cases (LOE
VI-B) (Table 4).
Dyslipidemia
The measurement of cholesterol, HDL-cholesterol and
triglycerides is recommended in all children and adolescents
with obesity since the age of 6. LOE I-A
The dyslipidemic pattern associated with childhood
obesity consists of a combination of elevated TG, de-
creased HDL-C, and low density lipoprotein cholesterol.
The prevalence of dyslipidemia among obese children
was 46–50.4% [48, 49]. Because the association of obes-
ity/hyperlipidemia (expecially hypertriglyceridemia) is
predictive of fatal and non fatal cardiovascular events in
adult life [50], the screening of dyslipidemia is recom-
mended, and should be repeated after 3 years, if nega-
tive, or more frequently if rapid increase in weight or
development of other cardiometabolic comorbidities oc-
curs [51, 52].
In the absence of national reference values, the diagnosis
of dyslipidemia is based on the criteria proposed by the
expert panel on integrated guidelines for cardiovascular
health and risk reduction in children and adolescents. LOE
III-B
The cut-offs for the definition of abnormal lipid levels as
proposed by the Expert Panel [51] are summarized in
Table 5. Recent studies have shown that the TG/HDL-C
ratio is associated with insulin resistance and early organ
Table 3 Criteria for the diagnosis of prediabetes and
diabetes mellitus
Prediabetes Impaired fasting glucose: plasma glucose (after 8 h of fasting)
between 100 (5.6 mmol/l) and 125 mg/dl (6.9 mmol/l)
Impaired glucose tolerance: plasma glucose after 2 h of the OGTT
between 140 and 199 mg/dl (7.8 mmol/l)
HbA1c between 5.7–6.4% (39–47 mmol/mol)
Type 2 diabetes Random glycemia ≥200 mg/dl (11.1 mmol/l) and
symptoms suggestive of diabetes (glycosuria without ketonuria,
polydipsia, weight loss). Confirmation with a second test is not
necessary. If symptoms are lacking, diagnosis is made whether one
of the following criteria is fullfilled:
1. Fasting glycemia ≥126 mg/dl after 8 h of fasting.
2. Glycemia ≥200 mg/dl after 2 h of the OGTT.
3. HbA1c ≥6.5% or≥ 48 mmol/l (IFCC reference method using high-
performance liquid chromatography (caution in pediatric age).
If one test is positive, the diagnosis must be confirmed by a second
test. Whenever the two tests are discordant, the patient should be
strictly monitored and the positive test repeated within 3–6 months.
If the diagnosis of diabetes is made, the assessment of the
autoimmune markers (ICA, GAD, IA2, IAA o ZnT8) is needed to
exclude type 1 diabetes.
Genetic screening for monogenic diabetes is recommended in the rare
cases presenting with obesity, diabetes, negative autoimmunity tests
and family history for T2D.
Table 4 Indication for the oral glucose tolerance test in
children and adolescents with overweight or obesity
Children with fasting plasma glucose ≥100 mg/dl or HbA1c
≥5.7–6.4% (39–46 mmol/mol)
Adolescents (> 10 years of age) or at onset of puberty with overweight
(BMI > 85th percentile) and at least one of the following risk factors:
- Family history of T2DM in first- or second-degree relatives;
- Race/ethnicity (African American, Latino, Native American, Asian
American, or Pacific Islander);
- Signs or conditions associated with insulin resistance (hypertension,
dyslipidaemia, polycystic ovary syndrome, acanthosis nigricans,
or small for gestational age at birth)
- Maternal history of diabetes or gestational diabetes during
the child’s gestation
- Non alcholic liver disease
- TG/HDL-Cholesterol ≥2.2
- Fasting plasma glucose ≥86 mg/dl
- TG > 100 mg/dl and fasting plasma glucose > 80 mg/dl
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damage (heart, liver, and carotid) [53–55]. The Tg/
HDL-C > 2.2 can be considered as a marker of atherogenic
dyslipidemia and an altered cardiometabolic risk profile in
obese children in Italy [55, 56] (LOE V-A). Children
with TG ≥ 500 mg/dL or LDL-Cholesterol persistently
≥ 160 mg/dL need lipid specialist consultation [51].
Gastroenterological complications
Non-alcoholic fatty liver disease
The assessment of transaminases and liver ultrasound
is suggested in all children and adolescents with
obesity starting at age of 6 years. LOE V-B The preva-
lence of NAFLD in obese children is 38–46% [57, 58].
Bright liver on ultrasound examination, with or without
elevation of alanine aminotransferase (> 26 U/L in boys
and > 22 U/L in girls) suggests NAFLD [59]. Weight reduc-
tion and re-testing after 6 months are initially recom-
mended [60] (LOE III-A). If liver hyperechogenicity and/or
elevated alanine aminotransferase persist despite weight
loss, other causes of hepatic disease (i.e. viral hepatitis,
Wilson’s disease, autoimmune hepatitis, alpha 1 anti-tripsin
deficiency, etc.) should be investigated. If ALT persistently
exceeds twice the normal limit, the patient must be referred
to a pediatric hepatologist [61].
Liver biopsy is the gold standard for diagnosis, but its
invasiveness and the possible complications limit its use
only to selected cases [61] (LOE VI-A).
Assessment of biochemical markers (i.e. retinol-binding
protein 4, cytokeratine 18, hyaluronic acid) [62, 63] as indi-
cators of hepatic histological damage, or clinical-laboratory
scores as indicators of prognostic risk is not recommended
in the clinical practice [64, 65] (LOEV-D).
Non-invasive investigations (magnetic resonance, com-
puted tomography, elastography, ultrasound elastography)
[66] are promising but again their use is not recommended.
(LOE V-D).
NAFLD may be screened also in overweight children pre-
senting with waist-to-height ratio > 0.5 and the assessment
yearly repeated [67].
Gallstones
There is no evidence to recommend the screening for
colelithiasis. LOE IV-C
Gallstone disease occurs in approximately 2% obese chil-
dren and adolescents [68, 69]. The rate increases up to
5.9% in obese patients with rapid weight loss [70]. The
disease is rarely diagnosed, since it is symptomatic only
in 20% cases [69, 71] In the presence of pain, primarily
in the right upper quadrant, nausea and vomiting, as-
sessment of serum transaminases, gamma glutamil
transpherase, alkaline phosphatase, bilirubin and liver
ultrasonography are diagnostic [71–73].
Gastroesophageal reflux
Gastroesophageal reflux is suspected in the presence of
evocative symptoms (such as pyrosis, heartburn,
regurgitation). LOE VI-B
The prevalence of gastroesophageal reflux in obese chil-
dren and adolescents is 13–25% (diagnosis made through
questionnaires) [74–78]. Suggestive symptoms are pyrosis,
epigastralgia, regurgitation. Weight loss may improve
these symptoms. However, if symptoms persist or more
severe symptoms occur (dysphagia, vomit) despite weight
loss, referral for specialist investigations (gastrointestinal
contrast study, endoscopy and oesophageal pH or imped-
ance monitoring) and treatment is required [79].
Polycystic ovary syndrome
The components of the polycystic ovary syndrome should be
considered in all female adolescents with obesity. LOE VI-A
Polycystic ovary syndrome (PCOS) is characterized by
hyperandrogenism (acne, hirsutism and alopecia) and
ovary dysfunction (oligo-amenorrhea). It is associated
with increased risk of infertility, T2D, metabolic syn-
drome and cardiovascular disease in adulthood [80, 81].
In adult women, the diagnosis is based on at least two of
the following criteria: a) oligo-ovulation and/or anovula-
tion; b) clinical and/or biochemical signs of hyperandro-
genism; c) polycystic ovary [82]. Since there is no widely
accepted definition for PCOS in the teenage, it is sug-
gested to identify and treat the single components of the
syndrome [83]. Referral for specialist investigations is re-
quired to exclude other hyperandrogenic causes (con-
genital adrenal hyperplasia, androgen-secreting tumors,
Cushing syndrome/disease) [80–84].
Table 5 References values to define dyslipidemia according to
the Expert Panel on Integrated Guidelines for Cardiovascular
Health and Risk Reduction in Children and Adolescents60
Cathegory Acceptable Borderline-high High
Total cholesterol (mg/dl) < 170 170–199 ≥200
LDL-cholesterol (mg/dl) < 110 110–129 ≥130
Non HDL-cholesterol (mg/dl) < 120 120–144 ≥145
Triglycerides (mg/dl)
0–9 years < 75 75–99 ≥100
10–19 years < 90 90–129 ≥130
Acceptable Borderline-low Low
HDL-cholesterol (mg/dl) > 45 40–45 < 40
Lipids are determined after at least 12 h of fasting
LDL Cholesterol is calculated by the Friedewald’s formula as total Cholesterol
minus HDL cholesterol minus (Triglycerides/5) (provided that triglycerides
are < 400 mg/dl)
Non HDL cholesterol is calculated as total Cholesterol minus HDL Cholesterol
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Respiratory complications
Respiratory symptoms and signs should be sought in
children and adolescents with obesity. LOE V-A
The prevalence of respiratory problems, such as
asthma, obstructive sleep apnea syndrome (OSAS),
and obesity hypoventilation syndrome (OHS) is higher
in obese children and adolescents compared to the
general population [85, 86]. OSAS affects 13–59% of
obese children [85, 87–89]. The severity is strongly
associated with excess weight, while adeno-tonsillar
hypertrophy, skull-facial abnormalities, Afro-American
and Asian ethnicities are modulation factors [85, 90].
The OHS is less frequent, affecting 3.9% obese pa-
tients [89].
Children and adolescents may present with increased
breath rate, dyspnea after moderate efforts, wheezing,
chest pain. OSAS is associated with intermittent hypox-
emia, hypercapnia, and disrupted sleep. Specific symp-
toms and signs are: snoring/noisy breathing (> 3 nights/
week), pauses in breathing, mouth breathing, awaken-
ing headache that may persist during the day, daytime
sleepiness, inability to concentrate, poor academic per-
formance, hyperactivity, cognitive deficits. Rarely,
growth delay, systemic hypertension pulmonary and ar-
tery hypertension have been reported in severe obesity
[91, 92].
OHS is characterized by severe obesity, chronic day-
time alveolar hypoventilation (defined as PaCO2 levels
> 45 mmHg and PaO2 < 70 mmHg), a pattern of com-
bined obstruction and restriction, in absence of other
pulmonary, neuromuscular, metabolic, or chest dis-
eases that may justify daytime hypercapnia [89].
In the presence of respiratory symptoms/signs, trans-
cutaneous saturation of O2 should be determined; for
values < 95%, arterial blood emogasalysis should be per-
formed. If asthma and/or any other ventilatory dysfunc-
tion are suspected, respiratory function (spirometry,
pletismography, six minute walking test) should be mea-
sured. Allergological evaluation is not necessary, unless
a history of atopia is reported [86], neither is necessary
measuring the exhaled nitric oxide [93, 94]. Night poly-
somnography is the gold standard for diagnosis of sleep
disorders. The apnea/hypopnea index (ratio between
total number of apnea/hypopnea episodes and duration
of sleep in hours) indicates the severity (1–5 very mild;
5–10 mild; 10–20 moderate;> 20 severe). Alternatively,
overnight pulse oximetry can be used, which is very spe-
cific but less sensitive. Otorhinolaryngoiatric or odon-
toiatric evaluations complete the diagnostic work-up.
Cardiology referral should be considered in severe and
long-lasting OSAS for assessing lung or systemic hyper-
tension, and left ventricular hypertrophy [91]. Cognitive
assessement may be required to assess neurocognitive
damage and behavioral disorders [95].
Orthopaedic complications
Orthopaedic complications should be sought in the
presence of musculoskeletal pain and joint limit ation at
the lower extremity. LOE V-A
Severity of obesity and sedentary lifestyle influence the
morphology of osteo-cartilaginous structures and growth
plate, leading to serious orthopedic consequences [96, 97].
The main orthopaedic complications are: slipped capital
femoral epiphysis, Blount’s disease or tibia vara, valgus
knee, flat foot [98–103].
Slipped capital femoral epiphysis may affect one or
both hips; it usually occurs during the pubertal growth
spurt. Hip pain and/or knee pain, an acute or insidious
onset of a limp and decreased range of motion in the
affected hip are the main symptoms/signs [104]. Blount
disease is characterized by the varus deformity of the
leg. Clinical manifestation is the instability of the knee in
walking and lateral movements, simulating lameness
[100]. Valgum knee is characterized by the deformity of
the femoro-tibial angle in valgism; other deformities are
associated, such as deviations in rotation of the tibia
[101, 102]. Flat foot is characterized by flattening of the
medial arch and heel valgus. Pain may be reported along
the medial part of the foot, with more specific com-
plaints after exercises or long walks [105].
Although obesity may exhibit higher risk of fracture, the
measurement of bone density is not recommended. LOE V-D
The risk of fracture is increased in obese children, even
for low energy injuries [106–108]. Inactivity, abnormal-
ities in biomechanics of locomotion, inadequate balance
may expose the obese child to fall and consequently to
fracture, especially of the forearm [109]. There is no evi-
dence that obesity results in a reduction of bone density
[110]: while some studies have described an increased or
normal bone mineral content, others reported a reduced
bone mass in relation to bone size and weight [107].
Renal complications
There is insufficient evidence to recommend screening of
kidney complications in non-diabetic and non-hypertensive
children and adolescents with obesity. LOE IV-D
In adults, obesity is an independent risk factor for
chronic kidney disease [111]. Obesity complication, (i.e.
hypertension, dyslipidemia, insulin resistance, T2D, in-
flammatory state, autonomous system dysfunction) in-
deed, can alter the kidney function [112]. Peculiar to
obesity, the obesity-related glomerulopathy is a second-
ary form of segmental focal glomerulosclerosis occurring
tipically in obese patients and that improves after weight
loss [112].
Obesity is likely to be a risk factor for chronic renal
disease in children too. Indeed, children with renal dis-
ease have BMI higher than healthy population [113] and
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kidneys transplanted from obese donors have reduced
glomerular filtration and higher rate of dysfunction than
the kidneys obtained from normal weight donors [114].
In the light of current evidence [115–119], the assess-
ment of microalbuminuria is not recommended in
non-diabetic and non-hypertensive obese children (LOE
IV-D). Individual cases of severe obesity (BMI > 40) that
may be associated with proteinuria in the nephrotic
range remain to be evaluated individually (LOE VI-C).
Idiopathic endocranic hypertension
Headache, vomiting, photophobia, transiently blurred
vision, diplopia should be sought in subjects with
overweight/obesity, especially if adolescents. LOE V-A
Idiopathic endocranial hypertension is rare but poten-
tially serious condition that can cause permanent loss of
vision [120–122]. Prevalence and risk of recurrence in-
crease with the severity of BMI [123–125]. Some symp-
toms occur frequently in adolescents as in adults
(headache, vomiting, photophobia, transiently blurred vi-
sion, diplopia), while irritability, apathy, drowsiness, diz-
ziness, cervical and dorsal pain are less frequent [123,
126]. The diagnosis is based on the presence of in-
creased intracranial pressure documented with a lumbar
puncture, papilledema, normal neurologic examination
results (except for cranial nerves), normal cerebrospinal
fluid composition, normal appearance of neuroimaging
studies, and no other identifiable cause of increased
intracranial pressure [127].
Migraine and chronic headache
Promoting healthy lifestyle habits and weight control can
be a protective factor of migraine and chronic headache.
LOE V-B
Recent studies have reported greater risk of episodic or
recurrent migraine or daily chronic headache or tension
headache in obese children and adolescents than the
normal population [128, 129]. Some drugs used for
headache and migraine have weight gain as side effect
[129]. Negative lifestyle factors, which may influence the
prevalence of recurrent headache, are possible targets
for preventive measures [130]. An intervention study re-
ported improvement in migraine symptoms after weight
loss [131].
Psychosocial correlates
Psychosocial discomfort may affect therapeutic success,
therefore it should be identified as part of the multi-
disciplinary assessment. LOE V-A
Recognition of psycho-social correlates (unsatisfactory body
image, depressive and anxiety symptoms, loss of eating con-
trol, weight concern, dysfunctional social relationships, in-
activity due to problematic body image, obesity-related
stigma, low self-esteem, academic failure) is crucial to
promoting specific strategies that improve the results in
weight loss programs [132–134]. Although obesity is not a
psychopathological and behavioral disorder, referral for spe-
cialist consult is needed in the suspicious of depressive and/
or anxious symptoms, dysmorphophobic traits, suicidal
risk, and eating disorders [135, 136].
Binge eating disorder
The presence of binge eating disorder should be considered
in the multi-professional assessment of an obese child or
adolescent. LOE V-B
Binge Eating Disorder (BED) is the most common Nutrition
and Eating Disorder found in pediatric obesity. It is indica-
tive of psychopathology and is a serious risk factor for the
development of obesity, especially in the presence of family
history of obesity and marked negative experiences coupled
with factors predisposing to psychiatric disorders [137]. BED
is often preceeded by uncontrolled eating since childhood,
occasional bulimia, obesity, but also by an attention deficit
and hyperactivity disorder [136–138]. Upon referral to ap-
propriate medical subspecialists and/or mental health
personnel, the diagnosis of BED is critical to the therapeutic
success. It may be necessary associating psychological and
pharmacological therapy (only in selected cases) within the
weight-loss treatment program [136, 137, 139].
Treatment
Changes in diet and lifestyle leading to a negative caloric
balance is recommended to gradually reduce the BMI.
LOE I-A
The main objective is a permanent change in the child’s
eating habits and lifestyle, rather than attaining rapid
weight loss through low-calorie diets. It is indispensable
involving the whole family and setting realistic goals.
Further goals:
 maintaining an appropriate growth rate and
achieving an healthier weight-to-height ratio;
 reducing weight excess (without necessarily
achieving the ideal weight), in particular the fat
mass, while preserving the lean mass;
 maintaining or promoting good mental health
(self-esteem, correct attitudes toward food and
body image, health related quality of life);
 treatment and improvement/resolution of
complications, if present, in the shortest time
possible;
 achieving and mantaining a healthier weight-to-height
ratio and preventing relapses.
Diet
A balanced and varied diet is recommended (LOE I-A)
The classic diet-therapy based on the prescription of a
low calorie diet is not effective in the medium/long term
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with relapses and failures, increased risk of dropout and
progression into more complicated forms [140] (LOE
III-B).
The educational process starts from the assessment of
the child’s and family’s dietary habits, by means of the
assessment of meal composition, portions, frequency of
food intake, food preferences or aversions, use of con-
diments, cooking methods and food presentation
[141–145] (LOE I-A).
Food diary is an excellent tool for assessing eating be-
havior; it should be compiled by the child together with
the parents or by the adolescent and evaluated by the
operator [146, 147] (LOE I-B).
Dietary advice
1. Eat 5 meals a day (three meals and no more than
two snacks) [148] (LOE V-B)
2. Have an adequate breakfast [149] (LOE II-B)
3. Avoid eating between meals [150] (LOE III-B)
4. Avoid high-energy and low nutrient density foods
(eg. sweetened or energizing drinks, fruit juices, fast
food, high-energy snack) [151, 152] (LOE III-B)
5. Increase intake of fruit, vegetables and fiber rich
cereals [153, 154] (LOE VI-A)
6. Limit portions [155, 156] (LOE I-A)
If a hypocaloric diet is needed, it should fulfill the
National Recommended Energy and Nutrient Intake
Levels, based on sex, age and ideal weight for stature (pro-
teins 1 g/kg/day; carbohydrates 45–60% of total calories;
simple sugars < 15% of total calories, lipids 20–35% of
total calories starting from 4 years of age, saturated fatty
acids < 10% of total calories) [157] (LOE VI-A).
Efficacy of dietary regimens
There are currently no randomized controlled trials
(RCTs) examining the effects of different diets on child’s
weight and body composition, regardless of potential
confounders such as treatment intensity, behavioral or
physical activity strategies [158, 159].
Very low caloric diet
It is the most effective regimen in terms of weight loss
[160]. One example is the protein-sparing modified fast
(600–800 kcal/day, protein 1.5–2 g/kg ideal weight, car-
bohydrates 20–25 g/day, multivitamins + minerals, water
> 2000 ml/day), which can be prescribed in selected pa-
tients with severe obesity, under close medical surveil-
lance and in specialized pediatric centers. The aim is to
induce rapid weight loss (duration of this restrictive diet
no longer than 10 weeks) followed by a less restrictive
diet regimen balanced in macronutrients. RCTs are not
available to evaluate medium to long-term efficacy
compared to other diet-therapies and possible adverse
effects on growth (LOE III-C).
Traffic light and modified traffic light diets
Reduced caloric intake (1000–1500 kcal/day) is achieved
trough categories of foods grouped by nutrient density
[161]. They were found to produce a significant im-
provement of BMI in 8–12 year old children even in the
long term [162] (LOE III-C).
Non-restrictive approach
It does not consider a given caloric intake or nutrient
composition, rather it focuses on the consumption of
low-fat and high-nutrient density foods (LOE III-C).
Replacement meals
They are not recommended, since efficacy and safety
have not been tested in children/adolescents.
No significant effect has been demonstrated for diets
with specific macronutrient composition and medium
caloric content in children. In particular:
Hypocaloric diets with low glycemic index and low glycemic
load
Although an effect on satiety is suggested, their superior-
ity compared with other dietary approaches has not been
proved over the medium term [163–165] (LOE I-C).
Exercise
It is recommended to associate physical exercise to diet.
LOE I-A
Physical exercise ameliorates body composition and re-
duces cardio-metabolic risk factors. [166–171]. Change
in body composition (in particular fat reduction) rather
than reduced BMI is sensitive to evaluating the effective-
ness of exercise [166, 172].
It has not yet been proven which is the ideal exercise
for obese children [170]. Low evidence demonstrates
that combining aerobic and resistance exercises results
in fat mass reduction, especially with programs of at
least 2 weekly sessions and duration > 60 min [173]
(LOE I-B).
The evidence is limited that exercising at higher intensity is
more effective in modifying the body composition (LOE I-B).
Owing to difficulty of obese subjects to practice exercise
at high intensity, there is no evidence that vigorus efforts
result in greater body fat reduction [166]. Children and
adolescents should practice 60 min or more of physical
activity every day, which should be mainly represented
by aerobic exercises at least of moderate intensity; re-
sistance exercises are suggested for at least 3 times a
week, adjusted to the physical abilities of the obese
child [174, 175]. Examples of aerobic and resistance
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exercises for obese children and adolescents are synthe-
tized in Table 6. The practice of recreational activities and
sports that involve a large amount of body mass such as
swimming, soccer, basketball, volleyball, handball, rugby
or require anaerobic and neuromuscular power, such as
gymnastics or judo is encouraged. In severe obesity exer-
cises that put constant weight or repeated impact on the
child’s legs, feet and hips should be avoided.
Sedentary behaviors
It is suggested to reduce the time spent in sedentary
behaviours (television viewing, videogaming, internet surfing).
LOE II-B
Weight gain may be only partially due to sedentary be-
haviors [176–179]; in the case of television viewing, it
may be associated with overfeeding [180]. Interventions
targeting sedentary behaviour were more effective in
children aged 5–12 years [181].
Use of active video games may be suggested to increase daily
energy expenditure in obese and sedentary children. LOE I-B
Active video games represent an additional strategy to
reduce sedentary behaviors. They do not replace ‘real’
sports activities, but can contribute to increase energy
expenditure beyond the sedentary activity threshold,
provided they are supervised by adults [182–187].
The systematic use of active video games for weight loss and
improvement of body composition is not discouraged. LOE III-C
While studies are not consistent with the recommendation
to use active video games to obtain weight loss or improve
body composition, their use is not recommended but neither
discouraged to obtain other effects (improvement in vascular
response, heart rate and VO2max or obesity-related comor-
bidities; positive psycho-behavioral and psycho-social effects)
[182–184].
Cognitive and family-based behavioral therapy
Cognitive behavioral treatment or family-based behavioral
treatment are both recommended to favor better adhesion
to diet and physical activity. Cognitive behavioral treatment
LOE III- B; family-based behavioral treatment LOE I- A
Cognitive behavioral techniques are effective. Never-
thless, they are not easily applicable requiring spe-
cific training of the multidisciplinary team [188–
190]. The most effective techniques are goal setting,
self-monitoring (through food and physical activity
diaries), contingency training, stimulus control, posi-
tive reinforcement, cognitive restructuring, problem
solving [191].
Family-based behavioral treatments involve multi-
component interventions aimed at changing the lifestyle
of the whole family, with goals shared between parents
and children [191–194]. Interventions in which parents
are active participants are more effective than interven-
tions in which they are not encouraged to make their own
behavioral changes. On the other hand, family-based ther-
apies require greater investment of resources in terms of
time and staff involved [188, 190, 192–198]. In children,
they are more effective than treatments not involving par-
ents. There is no robust evidence demontsrating their su-
periority in adolescents [189, 190, 194] (LOE I-A).
Therapeutic education has been proposed in the recent
years, using tools of cognitive-behavioral approach and
motivational interview, such as reflective listening, thera-
peutic alliance, family approach, modeling, motivational
counseling, narrative approach, positive reinforcement,
goal setting, negotiating treatment objectives. It requires
professional skills of all the team members with ongoing
training [199–201] (LOE VI-B).
Child Appetite Awareness Training and Cue Exposure
Treatment are still considered experimental and require
further studies [202, 203] (LOE V-C).
Indicators of successful treatment
The BMI standard deviation score is recommended to
estimate weight loss. LOE V-B
The reduction of the BMI Standard Deviation Score
(BMI-SDS) is the best indicator of the weight loss amount
taking into account the patient’s age and gender [204]. A
reduction > 0.5, but even > 0.25 (consistent with a 1 kg/m2
BMI reduction or stable weight for more than 1 year in a
growing child) was associated with improved body com-
position and decreased cardio-metabolic risk [205].
Waist circumference and waist/height ratio can be
used to monitor abdominal fat variations but are subject
to error and offer no benefit over BMI [204, 206–208].
The same is true for the skinfold thicknesses [204, 209].
Other behavioral indicators (related to diet, lifestyle,
physical fitness or quality of life) can be considered if no
substantial reduction in the BMI-SDS occurs. LOE VI-B
Since the percentage of weight loss is generally low,
evaluation based solely on the BMI-SDS may induce a
sense of failure in the family and healthcare workers. In
order to maintain the adherence to treatment, a stable
modification of diet, physical activity and sedentary be-
havior, the increase of physical fitness and improvement
Table 6 Examples of aerobic and resistance exercises suggested
for obese children and adolescents
Aerobic
exercisesa
exercises on treadmill, cycle ergometer, elliptical trainer
water activities (swimming or water aerobics)
Resistance
exercisesa
body weight exercise (push-ups, sit-ups, abdominal
crunches), lifting free weights, using weight training
machines and elastic resistance bands, circuit training
aunder qualified supervision
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of the quality of life should be considered as index of
good compliance [210, 211].
The scarce effect of treatment in the long term demands
the development of long-lasting care models and their
validation. LOE VI-B
The effectiveness of treatment programs based on diet
and lifestyle on BMI-SDS reduction was shown only in
the short term (6–12 months) [167, 212]. In a European
multicentre study, the success rate (BMI SDS reduction
> 0.25) was 7% at 2 years; it reached 50% in a few num-
ber of centers, which differed for the greater intensity of
intervention and training of the multi-disciplinary team
[213, 214]. Only two national studies based on diet edu-
cation, cognitive or cognitive-behavioral strategies and
family involvement reported BMI-SDS reduction of 0.44
after three years [199] and 1.49 after 5 years of follow up
[188], respectively.
It is necessary to monitor the possible onset of eating
disorders, especially when the weight loss is rapid. LOE IV-A
Dissatisfaction with body image may be related to the
onset of eating disorders, especially bulimia nervosa and
binge eating, but also of anorexia nervosa [215–218].
Diet education undertakings can accentuate the per-
ceived stigma in subjects with obesity, causing drastic
strategies of weight control [219, 220]. In some cases,
the onset is triggered by an initially desired restriction of
food, which then becomes uncontrollable. Careful evalu-
ation of excessive weight variations and related bodily
experience, especially when hypocaloric diets are pre-
scribed, is recommended [217–219, 221].
Pharmacological intervention
Pharmacological therapy can only be applied after the failure
of the multidisciplinary lifestyle intervention. LOE VI-B
When clinically significant weight loss cannot be achieved
through lifestyle-based interventions, use of drugs is con-
sidered, especially in severe obesity with cardiometabolic,
hepatic or respiratory disorders [222–226]. Management
of drugs should be done in specialist centers [225].
Orlistat is the only drug available for the treatment of
children and adolescents with severe obesity age. LOE II-B
Few studies, with small sample size and short duration,
are available on the effects of anti-obesity medications in
pediatric age [227–230]. Orlistat (tetra-hydro-lipstinate)
is the only drug approved for the treatment of obesity in
pediatric age. It seems producing significant weight loss
and favoring behavioral changes [231–233]. It does not
affect the mineral balance, if the low-calorie diet is asso-
ciated with normal mineral content; on the contrary,
attention must be paid to prevent liposoluble vitamins
deficiency [234].
Bariatric surgery
Bariatric surgery is the ultimate solution in adolescents with
severe obesity and resistant to all other treatments,
especially when serious complications are present. LOE VI-B
The indications for surgery in the adolescent are (LOE
III-B) [235, 236]:
 BMI ≥35 kg/m2 with at least one severe
comorbidity, such as T2D, moderate to severe
obstructive sleep apnea (AHI > 15), idiopathic
endocranial hypertension, NAFLD with significant
fibrosis (Ishak score > 1).
 BMI ≥40 kg/m2 with less serious comorbidities, such
as mild sleep apnea (apnea/hypopnea index > 5),
hypertension, dyslipidemia, carbohydrate
intolerance.
More prudently other guidelines suggest a BMI >
40 kg/m2 with one severe comorbidity or > 50 kg/m2
with less serious comorbidities [223, 237].
Eligibility criteria are: adolescents with long lasting severe
obesity; a. previous failure of any dietetic, behavioral or
pharmacological intervention (after at least 12 months of in-
tensive treatment); b. family and social support in managing
the multidisciplinary care programs; c. decisional capacity
for surgical management and the post-surgery follow-up; d.
able to express the informed assent.
Surgery should be performed in a highly specialized center
that guarantees the presence of an experienced
multidisciplinary team. LOE III-A
The multidisciplinary team carefully evaluates the case
and poses the indication for the surgey taking care of
the pre-surgical assessment and post-surgical follow-up
[238, 239]. The preoperative phase includes a compre-
hensive assessment of the patient and the family, with
particular regard to physical and psychological maturation
of the adolescent and his/her adherence to treatment
[235, 237, 240]. Neuropsychiatric counseling should be
undertaken to identify cases at risk of psychotic disorders,
severe major depression, personality or eating disorders,
alcoholism and drug dependence [235–237]. In the post-
operative follow-up anthropometric, clinical and nutri-
tional assessment, and counseling are performed and early
or late complications are monitored.
For the adverse effect on height velocity, the adoles-
cent should have reached adequate skeletal maturation
or a pubertal stage IV according to Tanner [223, 236,
237, 241] (LOE III-A).
Contraindications to surgery are documented substance
abuse problem and/or drug dependencies; patient inability
to care for him/herself or to participate in life-long medical
follow-up, no long-term family or social support that will
warrant such care and follow-up; acute or chronic diseases
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even not directly associated with obesity threatening life in
the short term; high anesthetic risk; pregnancy or planned
pregnancy within the first two years after surgery, current
breast-feeding [237] (LOE VI-A).
Indication for surgery must be given on a case-by-case
basis by the multidisciplinary team (LOE VI-A)
Surgical procedures performed mostly by laparoscopy in
adolescents and supported by at least 3 years of follow-up,
are: a. restrictive interventions, including adjustable gastric
bandage and sleeve gastrectomy; b. restrictive/malabsorbi-
tive interventions, such as Roux-en Y gastric by-pass
(RYGB) (LOE III-B).
Although the RYGB is the gold standard, there is no
enough evidence to support this specific surgical tech-
nique compared to the others in terms of effectiveness,
side effects, long-term complications and benefits [239].
Although studies in adolescents have increased, lack of
RCTs makes it difficult to establish the effective efficacy
at this age. There is no evidence or expert opinion sup-
porting the efficacy of anticipating bariatric surgery to
the teenage with respect to adults. A recent Cochrane
review identified four RCTs in progress with expected
results in the near future [242]. Several non-randomized
and non-controlled trials were published with at least
three years follow-up on the use of bariatric surgery in
adolescents [243–247]. The published studies showed an
average BMI decrease of 16.6 kg/m2 after RYGB, 11.6 kg/m2
after gastric bandage and 14.1 kg/m2 after sleeve gastrec-
tomy [248]. All interventions have been associated with im-
provement or complete restoration of comorbidities. Most
studies are consistent in demonstrating improvement of the
quality of life [244, 248–250].
Care settings
For the multifactorial nature of obesity, variability in its
severity, and the health implications, treatment should be
conducted in multiple settings with different levels of
treatment. LOE III-A
Health services should be organized in a network of ser-
vices [150, 251–254]. Fundamental is the periodic training
of all network operators on motivational counseling, par-
enting and teamwork [251]. A child- and family-centered
approach is based on sharing simple and realistic objec-
tives about eating habits, sedentary behaviours, physical
activity, and verification of results related to improving
nutritional status, quality of life and complications if
present [255–258].
Primary care pediatricians represent the first level
treatment. LOE III-A
Primary care pediatricians’ responsibilities are summarized
in Table 7 [259, 260]. They are the reference point for obese
children/adolescents and their family, participating in the
various proposals for action and decisions, when a more ag-
gressive approach is proposed (e.g., hospitalization or sur-
gery). The efficacy of obesity treatment in the primary care
setting is still modest [261, 262], but it might improve if pe-
diatricians are assisted by other professionals experienced
in pediatric obesity (dieticians/nutritionist, psychologist)
and trained in family education and interdisciplinary work
[258, 259, 263, 264] (LOE VI-B).
District or hospital outpatient services represent the second
level of care. LOE VI-A
In the second level centers, the multidisciplinary team
(pediatrician, dietician and psychologist) experienced in
pediatric obesity defines the clinical condition of children
referred by the primary care pediatricians, and runs the
multidisciplinary intervention that is centered on diet edu-
cation and lifestyle modification [150, 260, 265, 266]. The
patient is referred to the third level health care center in
case of no response to the treatment, severe comorbidi-
ties, compromised psychological balance or significantly
impaired quality of life.
Specialized centers for pediatric obesity represent the third
level of care. LOE VI-A
Third level centers are organized on a multidisciplinary
and multiprofessional basis for comorbidity management
or bariatric surgery. They admit patients who are sus-
pected of secondary obesity or require more specialistic
diagnostic assessment and/or intensive care programs,
including bariatric surgery. They coordinate the net-
working activities as well as the training of operators
and promote research activities and intervention trials in
the context of specific protocols [267–271].
Transition
Pediatric obesity care should include a transition path from
pediatric to adult care. LOE VI-B
It is necessary to test a transition model for adolescents
with severe obesity and/or complications, particularly with
metabolic syndrome, NAFLD, hypertension [272–274]. Un-
fortunately, the experience is extremely limited for the high
drop-out, poor consideration about obesity as chronic ill-
ness, absence of pre-established pathways, possible transi-
tion to structures that follow the specific complications (eg.
hypertension), no availability of cost-effective models [275].
Prevention
Given the multifactorial nature of obesity, preventive in-
terventions should be designed to modify the environ-
mental and social determinants. Health and non-health
professionals should be involved in implementing
healthy food education and promoting physical activity.
Promotion of balanced nutrition and healthy lifestyle
implies the need to remodel economic, agricultural,
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industrial, environmental, socio-educational, recreational and
health policies, including those aimed at contrasting
socio-economic and ethnic minorities’ inequalities [276]. To
be effective, actions must be multicomponent and multilevel,
building agreements and alliances among many stakeholders,
including families, community organizations such as schools
and sport institutions, health care providers [277–279].
Primary prevention actions begin from the prenatal age,
involving the “Birth Pathway” within the family counselling
services, spanning to the adolescence with actions spread at
individual, family and community levels [260].
Prevention is based on behavioral modification starting
from the prenatal age. LOE I-A
Lifestyle-based interventions are able to achieve mild but
significant effects on dysfunctional behaviors (diet, physical
activity, sedentary behaviours) and BMI [280]. Maintaining
the BMI in a growing child is an important health objective.
The best results have been obtained in school settings and
in children 6–12 years [263]. Further studies are needed to
determine the effectiveness of preventive interventions in
children under 3 years and adolescents [281].
The family involvement is strongly recommended. LOE III-A
Similarly to treatment, preventive interventions involving
the whole family are recommended as more successful
and long lasting compared to child-centered interven-
tions, though they were more effective in children than
adolescents [263, 282–284]. Interventions targeting at spe-
cific behaviors, such as taking fruits and vegetables and re-
ducing sedentary behaviours have been found effective as
well [283].
Prenatal age
Women should start pregnancy with appropriate weight
and control their weight gain following an healthy lifestyle.
LOE III-A
An excessive weight gain during pregnancy is associated
with fetal macrosomy and increased risk of obesity
[285–290]. This effect is independent of maternal hyper-
glycemia, which is also a well-known risk factor for fu-
ture obesity [291]. Recommended gestational weigh gain
is between 11.5 and 16 Kg in normal weight women, 7
to 11.5 Kg, in overweight and 5 to 9 Kg in those who
with prepregnancy obesity [292].
Tobacco smoke in pregnancy is banned. LOE III-A
Maternal smoking in the perinatal age increased the risk
of overweight at age 7 regardless of birth weight; the risk
increased for maternal smoking not only in pregnancy but
also in the post-natal period. There was a dose-dependent
effect. Hence, smoking exposure must be banned in pre-
and post-natal life [293, 294].
Diet
First two years of life
Avoid excessive weight gain and/or increased weight-to-
length ratio from the very first months of life. LOE III-A
Early rapid weight gain increases the risk of overweight
and obesity in childhood [295]. Prevention in infants is
focused on quality, quantity and timing of food intake.
In particular:
Exclusive breastfeeding is recommended up to
6 months [296–299]. LOE III-A.
Solid foods and beverages other than breast milk or infant
formulas should be introduced no earlier than 4 months
and no later than 6 months [300–305]. LOE III-B.
Protein intake should be limited to less than 15% of
the daily energy intake [302, 306–309]. LOE I-B.
Reduction of lipid intake to percentages indicated for
adults is not recommended [310]. LOE II-D.
Sweetened drinks should be avoided [311]. LOE III-A.
There is insufficient evidence that complementary re-
sponsive feeding practices, such as baby-led weaning
(which is associated with early satiety-responsiveness ac-
quisition), are protective against obesity respect to usual
complementary feeding mode [312–314]. LOE V-C.
Table 7 Primary care pediatricians’ responsibilities
Conditions Responsabilities
Risk factors:
Prenatal life: first-degree familiarity for obesity, low socioeconomic status;
Neonatal life: small for gestational age, or macrosomic infant;
Postnatal life: no breastfeeding, early complementary feeding, excessive
weight gain in the first two years of life, early adiposity rebound
Monitoring the child’s weight and length linear growth
Educating to a balanced diet and healthy lifestyle since the
earliest years of life
Assuring appropriate timing of complementary feeding
Children and adolescents with overweight or moderate,
uncomplicated obesity
Early identification of children’s excess weight
Promoting parental awareness of children’s excess weight
Motivating and supporting the family to change, possibly
involving other professionals trained in childhood obesity
Severe obesity or psychological co-morbidity, or additional risk factors,
or biochemical alterations, or treatment failure within 4–6 months
Identification of severe obesity
Promoting parental awareness of children’s excess weight
Motivating and supporting the family to more intensive levels of care
Suspicion of secondary obesity Referral to specialized centers
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From preschool age to adolescence
Low energy density diet is recommended, based on the
principles of the Mediterranean diet, promoting at least
5 servings of fruit and vegetables and plant based pro-
teins [315]. Food should be distributed in no more than
5 daily meals and household consumption of meals
should be promoted [316, 317]. LOE V-A.
The use of fast food and fast food-based venues should
be limited [318, 319].LOE V-A.
Avoid sweetened drinks, including sports drinks and
juice additives; alcoholic and energy drinks should also
be avoided in adolescents [320–322]. LOE I-A.
Physical activity
It is recommended that children/adolescents spend on
average 60 min a day on moderate/vigorous physical
activity. LOE III-A
Prospective studies have shown a negative association
between levels of physical activity and overweight/obesity
[323, 324]. Even moderate physical activity is sufficient to
improve aerobic fitness, an important marker of metabolic
health which is independent of adiposity [325, 326]. 210,
211 Moderate physical activity is more effective and easier
to implement in children who are sedentary or over-
weight. The increase of physical activity levels can be
achieved starting from the age of 2–3 years by active play,
walking, using the tricycle, and after 5–6 years, promoting
also sports participation 2/3 times a week. Exercise should
primarily stimulate aerobic capacity, but also strength and
flexibility, be adequate to the child’s ability and stage of
physical and psychomotor development [174, 175, 327].
Sedentary behaviours
The use of television and electronic games is discouraged in
children < 2 years of age. LOE VI-B
Although there are no specific studies on the effects of
video exposure on overweight/obesity in this age group,
video exposure should be discouraged since it may dis-
turb sleep regularity [328, 329].
Sedentary behavior, especially the time spent in front of a
screen (TV, video games, computers, mobile phones, etc.)
should be reduced to less than 2 h a day in children > 2 years
of age. LOE III-B
The association between sedentary behaviour, obesity
and cardiometabolic risk factors is weak, and it is re-
duced when corrected for physical activity levels [330].
On the contrary, the evidence based on prospective
studies and RCTs show a strong relationship between
television hours, obesity and cardio-metabolic risk fac-
tors, presumably because overfeeding frequently occurs
[331, 332].
Several studies demonstrated a greater amount of tele-
vision hours in children who have a television in their
bedroom, but there is no clear evidence that its removal
reduces the duration of the video exposure [333]; on the
contrary the installation of an electronic television time
manager seems effective [334]. Decreasing sedentary be-
havior was more successful in reducing BMI in children
5–12 years [181]. Prospective studies showed that inter-
rupting prolonged sedentary periods with mild physical
activity had beneficial effects on metabolic outcomes in
adults [335]. Although evidence is lacking in pediatric
age, it is suggested breaking up prolonged sitting time at
home and school.
Sleep duration and quality
Adequate sleep duration and quality should be promoted in
infants, children and adolescents. LOE III-B
A short sleep duration is a potential risk factor for over-
weight/obesity through neuroendocrine and metabolic
influences [336, 337]. One meta-analysis of longitudinal
studies indicated a risk of obesity more than doubled in
children with a sleep duration lower than recommended
[338]. Three intervention studies aimed at changing
sleeping hours within a multicomponent obesity treat-
ment were not effective in reducing the BMI [339].
Waiting for stronger evidence, we endorse the recom-
mendation for optimal amount of sleep in children and
adolescents released by the American Academy of Sleep
Medicine [340] syntethized in Table 8. Turning off all
“screens” 30 min before bedtime is also suggested to en-
suring adequate sleep.
Involvement of school settings for implementing
preventive actions
It is recommended to include the school settings in obesity
prevention programs. LOE I-A
The school is institutionally devoted to the education of
children and is certainly a privileged area for the imple-
mentation of preventive actions. Studies support with
moderate/high evidence that promoting healthy nutri-
tion and physical activity at school prevent excessive
weight gain and reduce the prevalence of overweight/
obesity [341, 342]. The most effective and promising
changes are summarized in Table 9. [334].
Table 8 Recommended amount of sleep in children and
adolescents
4–12 months 12–16 h/day (including afternoon naps)
1–2 years 11–14 h/day (including afternoon naps)
3–5 years 10–13 h/day (including afternoon naps)
6–12 years 9–12 h/day
13–18 years 8–10 h/day
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Conclusions
This paper is a Consensus position document on the care
of pediatric obesity in children and adolescents produced
by experts belonging to the Italian Society for Pediatric
Endocrinology and Diabetology and the Italian Society of
Pediatrics, and endorsed by the main Italian scientific so-
cieties involved in tackling obesity and its complications.
Consistent evidences suggest that the disease-burden of
obesity on the overall health starts very early in life and is
particularly serious for the development of cardiometabolic
disease risk factors during childhood and adolescence and
the association with premature mortality in adults. Further-
more, the mechanical and psychosocial comorbidities
undermine physical functioning and the health-related
quality of life. Several systematic reviews and meta-analyses
on treatment and prevention indicate that weight control
may be obtained by multicomponent intervention focused
on a life-long change in the child’s eating habits and life-
style, involving the whole family and the surrounding social
environment (school, communities). The effectiveness of
treatment programs based on diet and lifestyle on excess
weight reduction was shown only in the short term. Further
study is needed to evaluate the effectiveness and safety of
the different modalities of treatment, including pharmaco-
therapy and/or bariatric surgery, in the long term.
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